Investor Relations

Comprehensive financial information, investor resources, and corporate governance details for Nova Pharmaceuticals.

View Financials
Pharmaceutical Company Financial Performance

Financial Highlights

Key financial metrics and performance indicators from our latest quarterly results.

$125M

Q3 2024 Revenue

+15% YoY Growth

$18M

Net Income

+12% YoY Growth

$25M

R&D Investment

+20% YoY Growth

14.4%

Net Margin

+2.1% YoY

Financial Reports

Access our latest financial reports, earnings releases, and investor presentations.

Q3 2024 Earnings Release
Dec 1, 2024

Third quarter 2024 financial results showing strong revenue growth and increased R&D investment.

PDF, 2.5MB Download
Q3 2024 Investor Presentation
Dec 1, 2024

Comprehensive investor presentation covering financial results, strategic initiatives, and outlook.

PDF, 4.2MB Download
Annual Report 2023
Mar 15, 2024

Comprehensive annual report covering full year 2023 performance, strategy, and corporate governance.

PDF, 8.5MB Download
ESG Report 2023
Apr 20, 2024

Environmental, Social, and Governance report highlighting our sustainability initiatives and impact.

PDF, 3.8MB Download

Stock Information

Current stock performance and trading information for Nova Pharmaceuticals.

Stock Performance

$45.20

Current Price

+2.15%

Day Change

$42.50

52-Week Low

$48.75

52-Week High

Trading Information
  • Exchange: Moscow Exchange
  • Ticker: NOVA
  • Market Cap: $2.1B
  • Volume: 125,000
  • P/E Ratio: 18.5

Corporate Governance

Information about our corporate governance structure and board of directors.

Board of Directors

Information about our board members, committees, and governance structure.

View Board
Governance Documents

Corporate governance policies, charters, and committee information.

View Documents
Ethics & Compliance

Code of conduct, ethics policies, and compliance programs.

View Policies

Investor Events

Upcoming investor events, earnings calls, and shareholder meetings.

Q4 2024 Earnings Call
Upcoming

Fourth quarter 2024 earnings call and investor presentation.

Date: March 15, 2025
Time: 10:00 AM MSK
Register
Annual Shareholder Meeting
Confirmed

Annual general meeting of shareholders to discuss company performance and strategy.

Date: May 20, 2025
Location: Moscow
Register

Investor Relations Contact

For investor inquiries, financial information requests, or shareholder services, please contact our investor relations team.

Contact IR Team Email Us